The invention concerns compounds of Formula (I) (Formula (I)) or pharmaceutically-acceptable salts thereof, wherein R1 and R2 have any of the meanings defined herein before in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
申请公布号
PH12015501584(A1)
申请公布日期
2015.10.05
申请号
PH12015501584
申请日期
2015.07.16
申请人
ASTRAZENECA A.B.
发明人
BARLAAM, BERNARD CHRISTOPHE;BERRY, DAVID;DELOUVRIE, BENEDICTE;HARRIS, CRAIG STEVEN;LAMBERT-VAN DER BREMPT, CHRISTINE MARIE PAUL;OUVRY, GILLES;REID, GARY PATRICK;TOMKINSON, GARY PETER
